SAN FRANCISCO -- (BUSINESS WIRE) -- Teladoc, the nation’s leading telehealth provider, announced today it has surpassed 7.5 million members, will complete more than 200,000 consultations this year and projects 2014 revenues will double for the second straight year.
“This explosive growth demonstrates the strong and accelerating demand for telehealth solutions which address many of the ailments plaguing health care today,” said Teladoc CEO, Jason Gorevic. “Telehealth is revolutionizing health care delivery. Employers who were previously asking what telehealth is are now embracing the Teladoc model as an integral part of their benefits while seeking to maximize its conclusive benefits for patient access, quality and affordability.”
Gorevic is presenting today at 10 a.m. PST at the 32nd Annual JP Morgan Healthcare Conference.
Teladoc is the nation’s first and largest provider of telehealth services, and leads the health care industry with the only fully integrated clinical, technology and member engagement solution for telehealth. Teladoc provides 24/7 access to affordable, high-quality medical care for adults and children experiencing non-emergency medical issues via phone, secure online video, mobile app or HealthSpot™ Station – a private, walk-in kiosk. Through a directly-managed network of U.S.-based, board-certified physicians, Teladoc will deliver more than 200,000 consultations in 2014.
Teladoc reports a 97 percent patient satisfaction rate and connects patients with a board-certified, state-licensed physician in an average of 16 minutes. Teladoc is the first and only telehealth provider to receive certification from the National Committee for Quality Assurance (NCQA) for its physician credentialing process, scoring 100 percent. Recognized by Fast Company as “One of World’s Most Innovative Companies in Health Care” in 2013, Teladoc partners with health plans, corporations, organizations and patients that seek accessible and affordable high-quality medical care.
For more information, please visit www.Teladoc.com.